Global Medical Cannabis Market (2022-2027) by Product Type Outlook, Applications, Form, Compound, End-Users, and Geography, IGR Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Global Medical Cannabis Market (2022-2027) by Product Type Outlook, Applications, Form, Compound, End-Users, and Geography, IGR Competitive Analysis, Impact of Covid-19, Ansoff Analysis


The Global Medical Cannabis Market is estimated to be USD 9.61 Bn in 2022 and is expected to reach USD 24.86 Bn by 2027, growing at a CAGR of 20.94%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the Global Medical Cannabis Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

The Global Medical Cannabis Market is segmented based on Product Type, Applications, Form, Compound, End-Users, and Geography.

  • By Product Type, the market is classified into Flower and Oil & Tinctures.
  • By Applications, the market is classified into Chronic Pain, Mental Disorders, Cancer, and Others.
  • By Form, the market is classified into Concentrated Oil, Cream, Inhaled Liquids, Supplement Capsule, and Tincture Spray.
  • By Compound, the market is classified into Balanced THC & CBD, Cannabidiol (CBD)-Dominant, Tetrahydrocannabinol (THC)-Dominant.
  • By End-Users, the market is classified into Pharmaceuticals Industry, Research and Development Centers, and Others.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.
Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Cannabis Sativa, Inc., Cara Therapeutics Inc., Growblox Sciences, Inc., Jazz Pharmaceuticals plc, VIVO Cannabis Inc., etc.

Countries Studied
  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)
IGR Competitive Quadrant

The report includes IGR Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Medical Cannabis Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

Infogence Global Research analyses the Global Medical Cannabis Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, Infogence Global Research has devised suitable strategies for market growth.

Why buy this report?
  • The report offers a comprehensive evaluation of the Global Medical Cannabis Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using IGR Positioning Quadrants, Infogence's Proprietary competitive positioning tool.
Report Highlights:
  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 IGR Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Demand for Medical Cannabis Chronic Compounds
4.1.2 Increasing Population and Rise in the Prevalence of Chronic Diseases
4.1.3 Raising Awareness About Benefits of Medical Marijuana
4.2 Restraints
4.2.1 High Pricing of Medical Cannabis
4.3 Opportunities
4.3.1 Emergence of Cannabis Legalization
4.4 Challenges
4.4.1 Intensive Energy Consumption and Maintaining Product Consistency for the Cultivation of Cannabis
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Medical Cannabis Market, By Product Type
6.1 Introduction
6.2 Concentrates
6.3 Flower
6.4 Leaves
6.5 Seeds
7 Global Medical Cannabis Market, By Applications
7.1 Introduction
7.2 Chronic Pain
7.3 Mental Disorders
7.4 Cancer
7.5 Others
8 Global Medical Cannabis Market, By Form
8.1 Introduction
8.2 Concentrated Oil
8.3 Cream
8.4 Inhaled Liquids
8.3 Supplement Capsule
8.4 Tincture Spray
9 Global Medical Cannabis Market, By Compound
9.1 Introduction
9.2 Balanced THC & CBD
9.3 Cannabidiol (CBD)-Dominant
9.4 Tetrahydrocannabinol (THC)-Dominant
10 Global Medical Cannabis Market, By End-Users
10.1 Introduction
10.2 Pharmaceuticals Industry
10.3 Research and Development Centers
10.4 Others
11 Americas’ Medical Cannabis Market
11.1 Introduction
11.2 Argentina
11.3 Brazil
11.4 Canada
11.5 Chile
11.6 Colombia
11.7 Mexico
11.8 Peru
11.9 United States
11.10 Rest of Americas
12 Europe’s Medical Cannabis Market
12.1 Introduction
12.2 Austria
12.3 Belgium
12.4 Denmark
12.5 Finland
12.6 France
12.7 Germany
12.8 Italy
12.9 Netherlands
12.10 Norway
12.11 Poland
12.12 Russia
12.13 Spain
12.14 Sweden
12.15 Switzerland
12.16 United Kingdom
12.17 Rest of Europe
13 Middle East and Africa’s Medical Cannabis Market
13.1 Introduction
13.2 Egypt
13.3 Israel
13.4 Qatar
13.5 Saudi Arabia
13.6 South Africa
13.7 United Arab Emirates
13.8 Rest of MEA
14 APAC’s Medical Cannabis Market
14.1 Introduction
14.2 Australia
14.3 Bangladesh
14.4 China
14.5 India
14.6 Indonesia
14.7 Japan
14.8 Malaysia
14.9 Philippines
14.10 Singapore
14.11 South Korea
14.12 Sri Lanka
14.13 Thailand
14.14 Taiwan
14.15 Rest of Asia-Pacific
15 Competitive Landscape
15.1 IGR Competitive Quadrant
15.2 Market Share Analysis
15.3 Strategic Initiatives
15.3.1 M&A and Investments
15.3.2 Partnerships and Collaborations
15.3.3 Product Developments and Improvements
16 Company Profiles
16.1 Aurora Cannabis Inc.
16.2 Cannabis Sativa, Inc.
16.3 CannaGrow Holdings, Inc.
16.4 Cannbit Ltd
16.5 Canopy Growth Corp
16.6 Cara Therapeutics Inc.
16.7 Cronos Group Inc.
16.8 Curaleaf Holdings Inc
16.9 Emerald Health Therapeutics, Inc.
16.10 Growblox Sciences, Inc.
16.11 Isodiol International Inc
16.12 Jazz Pharmaceuticals plc
16.13 Lexaria Corp.
16.14 Medical Marijuana, Inc.
16.15 OrganiGram Holding Inc.
16.16 The Hydropothecary Corp.
16.17 VIVO Cannabis Inc.
17 Appendix
17.1 Questionnaire

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings